The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Methylation determines fibroblast activation and fibrogenesis in the kidney
Open accessAbstract
Fibrogenesis is a pathological wound repair process that fails to cease, even when the initial insult has been removed. Fibroblasts are principal mediators of fibrosis, and fibroblasts from fibrotic tissues fail to return to their quiescent stage, including when cultured in vitro. In a search for underlying molecular mechanisms, we hypothesized that this perpetuation of fibrogenesis is caused by epigenetic modifications. We demonstrate here that hypermethylation of RASAL1, encoding an inhibitor of the Ras oncoprotein, is associated with the perpetuation of fibroblast activation and fibrogenesis in the kidney. RASAL1 hypermethylation is mediated by the methyltransferase Dnmt1 in renal fibrogenesis, and kidney fibrosis is ameliorated in Dnmt1+/− heterozygous mice. These studies demonstrate that epigenetic modifications may provide a molecular basis for perpetuated fibroblast activation and fibrogenesis in the kidney.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Self-citationJones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationHinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1993) · Nature · doi:10.1038/366362a0 · Cited by 1,964
Methylation-Induced Repression— Belts, Braces, and Chromatin
Bird, A. P., & Wolffe, A. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81532-9 · Cited by 1,827
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90228-3 · Cited by 1,691
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Self-citationFibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M., & Kalluri, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050513 · Cited by 876
Self-citationTGF-ß Signaling in Renal Disease
Bo[Combining Diaeresis]ttinger, E. P., & Bitzer, M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000033611.79556.ae · Cited by 711
Molecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
Witzgall, R., Brown, D., Schwarz, C., & Bonventre, J. V. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117214 · Cited by 603
The renal papilla is a niche for adult kidney stem cells
Oliver, J. A., Maarouf, O., Cheema, F. H., Martens, T. P., & Al-Awqati, Q. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420921 · Cited by 534
Lloyd, C. M., Minto, A. W., Dorf, M. E., Proudfoot, A., Wells, T. N. C., Salant, D. J., & Gutierrez-Ramos, J.-C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1371 · Cited by 496
Self-citationChanges in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications
Santini, V., Kantarjian, H. M., & Issa, J.-P. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00011 · Cited by 414
Signaling Interplay in Ras Superfamily Function
Mitin, N., Rossman, K. L., & Der, C. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.07.010 · Cited by 399
DNA methylation: Bisulphite modification and analysis
Clark, S. J., Statham, A., Stirzaker, C., Molloy, P. L., & Frommer, M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.324 · Cited by 362
Renal Fibroblasts and Myofibroblasts in Chronic Kidney Disease
Strutz, F., & Zeisberg, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050420 · Cited by 324
Self-citationMechanisms of tubulointerstitial fibrosis
Kuncio, G. S., Neilson, E. G., & Haverty, T. (1991) · Kidney International · doi:10.1038/ki.1991.63 · Cited by 289
An elaborate pathway required for Ras-mediated epigenetic silencing
Gazin, C., Wajapeyee, N., Gobeil, S., Virbasius, C.-M., & Green, M. R. (2007) · Nature · doi:10.1038/nature06251 · Cited by 282
Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development
Rothenpieler, U. W., & Dressler, G. R. (1993) · Development · doi:10.1242/dev.119.3.711 · Cited by 276
A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and Tumorigenicity
Kolfschoten, I. G. M., van Leeuwen, B., Berns, K., Mullenders, J., Beijersbergen, R. L., Bernards, R., Voorhoeve, P. M., & Agami, R. (2005) · Cell · doi:10.1016/j.cell.2005.04.017 · Cited by 273
Strutz, F., Zeisberg, M., Renziehausen, A., Raschke, B., Becker, V., Van Kooten, C., & Müller, G. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002579.x · Cited by 250
Self-citationDing, M., Cui, S., Li, C., Jothy, S., Haase, V., Steer, B. M., Marsden, P. A., Pippin, J., Shankland, S., Rastaldi, M. P., et al. (2006) · Nature Medicine · doi:10.1038/nm1460 · Cited by 212
Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease
Lin, J., Patel, S. R., Cheng, X., Cho, E. A., Levitan, I., Ullenbruch, M., Phan, S. H., Park, J. M., & Dressler, G. R. (2005) · Nature Medicine · doi:10.1038/nm1217 · Cited by 198
Rodemann, H. P., & Müller, G. A. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80352-0 · Cited by 183
Self-citationIschemic acute renal failure induces the expression of a wide range of nephrogenic proteins
Villanueva, S., Céspedes, C., & Vio, C. P. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00384.2005 · Cited by 168
Recent advances in neurofibromatosis type 1
Arun, D., & Gutmann, D. H. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200404000-00004 · Cited by 133
Jin, H., Wang, X., Ying, J., Wong, A., Cui, Y., Srivastava, G., Shen, Z.-Y., Li, E., Zhang, Q., Jin, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700153104 · Cited by 127
Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat
Chatterjee, P. K., Brown, P. A., Cuzzocrea, S., Zacharowski, K. D., Stewart, K. N., Mota‐Filipe, H., McDonald, M. C., & Thiemermann, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00722.x · Cited by 122
Muller, G. A., & Rodemann, H. P. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80351-9 · Cited by 97
Basile, D. P., Fredrich, K. M., Alausa, M., Vio, C. P., Liang, M., Rieder, M. R., Greene, A. S., & Cowley, A. W. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00329.2004 · Cited by 92
Identification of a Ras GTPase‐activating protein regulated by receptor‐mediated Ca2+ oscillations
Walker, S. A., Kupzig, S., Bouyoucef, D., Davies, L. C., Tsuboi, T., Bivona, T. G., Cozier, G. E., Lockyer, P. J., Buckler, A., Rutter, G. A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600197 · Cited by 90
Targeting TGF–β for treatment of disease
Border, W. A., & Noble, N. A. (1995) · Nature Medicine · doi:10.1038/nm1095-1000 · Cited by 77
Alterations in DNA methylation in human colon neoplasia
Feinberg, A. P., & Vogelstein, B. (1987) · Seminars in Surgical Oncology · doi:10.1002/ssu.2980030304 · Cited by 61
Forbes, J. M., Leaker, B. R., Hewitson, T. D., Becker, G. J., & Jones, C. L. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00253.x · Cited by 53
The epigenome as a molecular marker and target
Gius, D. R., Bradbury, C. M., Sun, L., Awwad, R. T., Huang, L., Smart, D. D., Bisht, K. S., Ho, A. S., & Nguyen, P. (2005) · Cancer · doi:10.1002/cncr.21395 · Cited by 23
Cited by
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Self-citationMechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Metadata
- Authors
- Bechtel, W., McGoohan, S., Zeisberg, E. M., Müller, G. A., Kalbacher, H., Salant, D. J., Müller, C. A., Kalluri, R., & Zeisberg, M.
- Venue
- Nature Medicine
- Published
- 2010-04-25
- Volume
- 16
- Issue
- 5
- Pages
- 544-550
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2063369009
- Cited by
- 639
- References
- 43
- FWCI
- 24.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
